Cargando…
The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment
The impact of breast cancer-related lymphedema (BCRL) on long-term quality of life is unknown. The aim of this study was to investigate the impact of BCRL on health-related quality of life (HRQoL) up to 10 years after breast cancer treatment. This regional population-based study enrolled patients tr...
Autores principales: | Jørgensen, Mads G., Toyserkani, Navid M., Hansen, Frederik G., Bygum, Anette, Sørensen, Jens A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169644/ https://www.ncbi.nlm.nih.gov/pubmed/34075045 http://dx.doi.org/10.1038/s41523-021-00276-y |
Ejemplares similares
-
Prospective Validation of Indocyanine Green Lymphangiography Staging of Breast Cancer-Related Lymphedema
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Adipose‐derived regenerative cells and lipotransfer in alleviating breast cancer‐related lymphedema: An open‐label phase I trial with 4 years of follow‐up
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial
por: Gulmark Hansen, Frederik C., et al.
Publicado: (2023) -
Indocyanine green lymphangiography is superior to clinical staging in breast cancer-related lymphedema
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Treatment of Breast Cancer‐Related Lymphedema with Adipose‐Derived Regenerative Cells and Fat Grafts: A Feasibility and Safety Study
por: Toyserkani, Navid Mohamadpour, et al.
Publicado: (2017)